Taro Tokui

3.7k total citations · 1 hit paper
25 papers, 2.7k citations indexed

About

Taro Tokui is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Taro Tokui has authored 25 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Taro Tokui's work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Amino Acid Enzymes and Metabolism (4 papers). Taro Tokui is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Amino Acid Enzymes and Metabolism (4 papers). Taro Tokui collaborates with scholars based in Japan, United States and Germany. Taro Tokui's co-authors include Takaaki Abe, Daisuke Nakai, Xing‐Zhen Chen, Richard F. Brubaker, Matthias A. Hediger, Bryan Mackenzie, Urs V. Berger, Hiroyasu Tsukaguchi, Michiaki Unno and Hiromu Yawo and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Taro Tokui

25 papers receiving 2.6k citations

Hit Papers

A family of mammalian Na+-dependent L-ascorbic acid trans... 1999 2026 2008 2017 1999 200 400 600

Peers

Taro Tokui
Dylan P. Hartley United States
Aldo D. Mottino Argentina
Francis R. Simon United States
Murad Ookhtens United States
Frederick A. Wilson United States
Dylan P. Hartley United States
Taro Tokui
Citations per year, relative to Taro Tokui Taro Tokui (= 1×) peers Dylan P. Hartley

Countries citing papers authored by Taro Tokui

Since Specialization
Citations

This map shows the geographic impact of Taro Tokui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taro Tokui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taro Tokui more than expected).

Fields of papers citing papers by Taro Tokui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taro Tokui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taro Tokui. The network helps show where Taro Tokui may publish in the future.

Co-authorship network of co-authors of Taro Tokui

This figure shows the co-authorship network connecting the top 25 collaborators of Taro Tokui. A scholar is included among the top collaborators of Taro Tokui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taro Tokui. Taro Tokui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kotsuma, Masakatsu, et al.. (2008). Novel Binding Mode of the Acidic CYP2D6 Substrates Pactimibe and Its Metabolite R-125528. Drug Metabolism and Disposition. 36(9). 1938–1943. 12 indexed citations
2.
Kotsuma, Masakatsu, Taro Tokui, Stefan Freudenthaler, & Kenji Nishimura. (2008). Effects of Ketoconazole and Quinidine on Pharmacokinetics of Pactimibe and Its Plasma Metabolite, R-125528, in Humans. Drug Metabolism and Disposition. 36(8). 1505–1511. 6 indexed citations
3.
Kotsuma, Masakatsu, Taro Tokui, Haruo Iwabuchi, et al.. (2007). CYP2D6-Mediated Metabolism of a Novel Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor, Pactimibe, and Its Unique Plasma Metabolite, R-125528. Drug Metabolism and Disposition. 36(3). 529–534. 4 indexed citations
4.
Nakai, Daisuke, Kenji Kawai, Yasushi Yoshigae, et al.. (2006). OATP1B1, OATP1B3, AND MRP2 ARE INVOLVED IN HEPATOBILIARY TRANSPORT OF OLMESARTAN, A NOVEL ANGIOTENSIN II BLOCKER. Drug Metabolism and Disposition. 34(5). 862–869. 84 indexed citations
5.
Nakai, Daisuke, et al.. (2004). Evaluation of the protein binding ratio of drugs by a micro-scale ultracentrifugation method. Journal of Pharmaceutical Sciences. 93(4). 847–854. 72 indexed citations
6.
Hosoya, Ken‐ichi, Masatoshi Tomi, Daisuke Nakai, et al.. (2004). Transporter mRNA Expression in a Conditionally Immortalized Rat Small Intestine Epithelial Cell Line (TR-SIE). Drug Metabolism and Pharmacokinetics. 19(4). 264–269. 8 indexed citations
7.
Mikkaichi, Tsuyoshi, Takehiro Suzuki, Tohru Onogawa, et al.. (2004). Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. Proceedings of the National Academy of Sciences. 101(10). 3569–3574. 221 indexed citations
8.
Adachi, Hisanobu, Takehiro Suzuki, Naoki Asano, et al.. (2003). Molecular characterization of human and rat organic anion transporter OATP-D. American Journal of Physiology-Renal Physiology. 285(6). F1188–F1197. 72 indexed citations
9.
Abe, Takaaki, Takehiro Suzuki, Michiaki Unno, Taro Tokui, & Sadayoshi Ito. (2002). Thyroid hormone transporters: recent advances. Trends in Endocrinology and Metabolism. 13(5). 215–220. 84 indexed citations
10.
Nakai, Daisuke, Rie Nakagomi, Yoshitake Furuta, et al.. (2001). Human Liver-Specific Organic Anion Transporter, LST-1, Mediates Uptake of Pravastatin by Human Hepatocytes. Journal of Pharmacology and Experimental Therapeutics. 297(3). 861–867. 178 indexed citations
11.
Abe, Takaaki, Masayuki Kakyo, Taro Tokui, et al.. (1999). Identification of a Novel Gene Family Encoding Human Liver-specific Organic Anion Transporter LST-1. Journal of Biological Chemistry. 274(24). 17159–17163. 437 indexed citations
12.
Kakyo, Masayuki, Michiaki Unno, Taro Tokui, et al.. (1999). Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter rlst-1. Gastroenterology. 117(4). 770–775. 85 indexed citations
13.
Tokui, Taro, Daisuke Nakai, Rie Nakagomi, et al.. (1999). Pravastatin, an HMG-CoA Reductase Inhibitor, Is Transported by Rat Organic Anion Transporting Polypeptide, oatp2. Pharmaceutical Research. 16(6). 904–908. 71 indexed citations
14.
Abe, Takaaki, Masayuki Kakyo, Hiroyuki Sakagami, et al.. (1998). Molecular Characterization and Tissue Distribution of a New Organic Anion Transporter Subtype (oatp3) That Transports Thyroid Hormones and Taurocholate and Comparison with oatp2. Journal of Biological Chemistry. 273(35). 22395–22401. 295 indexed citations
15.
Yamazaki, Masayo, et al.. (1996). TISSUE-SELECTIVE UPTAKE OF PRAVASTATIN IN RATS: CONTRIBUTION OF A SPECIFIC CARRIER-MEDIATED UPTAKE SYSTEM. Biopharmaceutics & Drug Disposition. 17(9). 775–789. 45 indexed citations
16.
Tokui, Taro, et al.. (1995). Evaluation of the uptake of pravastatin by perfused rat liver and primary cultured rat hepatocytes.. Pharmaceutical Research. 12(11). 1741–1745. 38 indexed citations
17.
Tokui, Taro, et al.. (1995). Delivery and cytotoxicity of RS-1541 in St-4 human gastric cancer cells in vitro by the low-density-lipoprotein pathway. Cancer Chemotherapy and Pharmacology. 36(1). 1–6. 7 indexed citations
18.
Magata, Yasuhiro, Hideo Saji, Taro Tokui, et al.. (1993). High reactivity of [11C]CH3I with thiol group in the synthesis of C-11 labeled radiopharmaceuticals. Annals of Nuclear Medicine. 7(3). 173–177. 1 indexed citations
19.
Tokui, Taro, et al.. (1992). Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture. Biochemical Pharmacology. 43(4). 667–670. 59 indexed citations
20.
Saji, Hideo, et al.. (1984). Constant infusion system of 15O labeled water.. RADIOISOTOPES. 33(9). 611–616. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026